CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-17 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $11.67 | $584K | 1,297,447 |
| 2024-12-17 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $11.67 | $584K | 1,098,499 |
| 2024-12-13 | Chakma Justin Chief Business Officer | Option exercise | +27,272 | $1.44 | $39K | 163,652 |
| 2024-12-13 | Chakma Justin Chief Business Officer | Sale | −27,272 | $12.06 | $329K | 136,380 |
| 2024-12-13 | Chakma Justin Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −27,272 | 55,461 | ||
| 2024-12-12 | Chakma Justin Chief Business Officer | Option exercise | +117,333 | $0.84 | $99K | 253,713 |
| 2024-12-12 | Chakma Justin Chief Business Officer | Sale | −117,333 | $12.27 | $1.4M | 136,380 |
| 2024-12-12 | Chakma Justin Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −117,333 | 119,047 | ||
| 2024-12-12 | Dorsey Brian Chief Operating Officer | Option exercise 10b5-1 | +25,000 | $0.64 | $16K | 31,024 |
| 2024-12-12 | Dorsey Brian Chief Operating Officer | Sale 10b5-1 | −25,000 | $12.30 | $307K | 6,024 |
| 2024-12-12 | Dorsey Brian Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 21,828 | ||
| 2024-12-11 | Dorsey Brian Chief Operating Officer | Option exercise 10b5-1 | +15,000 | $0.64 | $10K | 21,024 |
| 2024-12-11 | Dorsey Brian Chief Operating Officer | Sale 10b5-1 | −15,000 | $12.43 | $186K | 6,024 |
| 2024-12-11 | Dorsey Brian Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 46,828 | ||
| 2024-12-10 | Chakma Justin Chief Business Officer | Option exercise | +50,000 | $0.84 | $42K | 186,380 |
| 2024-12-10 | Chakma Justin Chief Business Officer | Sale | −50,000 | $13.15 | $658K | 136,380 |
| 2024-12-10 | Chakma Justin Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2024-12-10 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $13.17 | $658K | 1,246,494 |
| 2024-12-10 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $13.16 | $658K | 1,148,499 |
| 2024-12-10 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $13.17 | $658K | 1,246,494 |
Page 6 of 14 · 267 trades